Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
Line 341: | Line 341: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vessel wall disorders | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vessel wall disorders | ||
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Metabolism|Metabolic]] and [[Inflammation|Inflammatory]] Disorders | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Metabolism|Metabolic]] and [[Inflammation|Inflammatory]] Disorders | ||
! colspan="2" | | ! colspan="2" align="left" style="padding: 5px 5px; background: #DCDCDC;" | | ||
* Acute febrile illnesses | * Acute febrile illnesses | ||
* [[Cryoglobulinemia|Mixed cryoglobulinemia]] | * [[Cryoglobulinemia|Mixed cryoglobulinemia]] | ||
* [[Monoclonal gammopathy|Monoclonal gammopathies]] | * [[Monoclonal gammopathy|Monoclonal gammopathies]] | ||
* | * [[Rocky Mountain spotted fever]] | ||
* [[Vitamin C]] | * [[Vitamin C deficiency]] | ||
* [[Cushing's syndrome|Cushing’s syndrome]] | * [[Cushing's syndrome|Cushing’s syndrome]] | ||
* Chronic [[glucocorticoid]] therapy | * Chronic [[glucocorticoid]] therapy | ||
* [[Vasculitis]] such as Henoch-Schönlein Purpura | |||
* [[Vasculitis]] such as Henoch-Schönlein | | align="left" style="background:#F5F5F5;" | | ||
| | * History of the underlying disease | ||
* History of the underlying disease | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |± | ||
|± | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl or ↑ | ||
|Nl or ↑ | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |− | ||
|− | |||
|- | |- | ||
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |Inherited Disorders of the [[Vessel wall|Vessel Wall]] | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |Inherited Disorders of the [[Vessel wall|Vessel Wall]] | ||
! colspan="2" | | ! colspan="2" align="left" style="background:#DCDCDC;" | | ||
* [[Marfan's syndrome|Marfan’s syndrome]] | * [[Marfan's syndrome|Marfan’s syndrome]] | ||
* [[Ehlers-Danlos syndrome]] | * [[Ehlers-Danlos syndrome]] | ||
* [[Pseudoxanthoma elasticum]] | * [[Pseudoxanthoma elasticum]] | ||
* [[Hereditary hemorrhagic telangiectasia]] ([[Hereditary hemorrhagic telangiectasia|HHT]], or [[Osler-Weber-Rendu|Osler-Weber-Rendu disease]]) | * [[Hereditary hemorrhagic telangiectasia]] ([[Hereditary hemorrhagic telangiectasia|HHT]], or [[Osler-Weber-Rendu|Osler-Weber-Rendu disease]]) | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* Positive family history | * Positive family history | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
|± | | align="center" style="background:#F5F5F5;" |± | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl or ↑ | | align="center" style="background:#F5F5F5;" |Nl or ↑ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! rowspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Coagulation factor disorders | ! rowspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Coagulation factor disorders | ||
<ref name="pmid28966616" /> | <ref name="pmid28966616" /> | ||
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Fibrinogen]] deficiency | ! align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Fibrinogen]] deficiency | ||
! colspan="2" |Different types of the [[fibrinogen]] disorders: | ! colspan="2" align="left" style="padding: 5px 5px; background: #DCDCDC;" | | ||
Different types of the [[fibrinogen]] disorders: | |||
* [[Fibrinogen#Congenital afibrinogenemia|Congenital afibrinogenemia]] | * [[Fibrinogen#Congenital afibrinogenemia|Congenital afibrinogenemia]] | ||
* [[Fibrinogen#Congenital hypofibrinogenemia|Congenital hypofibrinogenemia]] | * [[Fibrinogen#Congenital hypofibrinogenemia|Congenital hypofibrinogenemia]] | ||
Line 397: | Line 397: | ||
* [[Fibrinogen#Hereditary fibrinogen A.CE.B1-Chain amyloidosis|Hereditary fibrinogen Aα-Chain amyloidosis]] | * [[Fibrinogen#Hereditary fibrinogen A.CE.B1-Chain amyloidosis|Hereditary fibrinogen Aα-Chain amyloidosis]] | ||
* [[Fibrinogen#Acquired dysfibrinogenemia|Acquired dysfibrinogenemia]] | * [[Fibrinogen#Acquired dysfibrinogenemia|Acquired dysfibrinogenemia]] | ||
| align="left" style="background:#F5F5F5;" | | |||
| | |||
* [[Epistaxis]] | * [[Epistaxis]] | ||
* Easy [[Bruise|bruising]] | * Easy [[Bruise|bruising]] | ||
Line 408: | Line 406: | ||
* Bleeding after [[dental surgery]] or tooth extraction | * Bleeding after [[dental surgery]] or tooth extraction | ||
* AbNl bleeding during or after injury, surgery, or childbirth | * AbNl bleeding during or after injury, surgery, or childbirth | ||
* [[Gastrointestinal tract|Gastrointestinal]] [[hemorrhage]] | * [[Gastrointestinal tract|Gastrointestinal]] [[hemorrhage]] | ||
* [[Cerebral hemorrhage]] | * [[Cerebral hemorrhage]] | ||
* [[Thrombosis]] | * [[Thrombosis]] | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
|± | | align="center" style="background:#F5F5F5;" |± | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Impaired fibrin cross linking or clot dissolution | * Impaired fibrin cross-linking or clot dissolution | ||
* Mild or severe bleeding idepend on levels of functional fibrinogen | |||
* | * Variable age of onset | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory |
Revision as of 16:15, 19 October 2018
Differential Diagnosis
Different causes of the bleeding disorders can be differentiated based on their clinical manifestation and laboratory findings.
These features have discussed in the below table:
Category | Subcategory | Disease | History | Clinical manifestation | Laboratory testing | Comments | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | ||||||
Platelet disorders | Thrombocytopenia | Infection-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |
Medications-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | Most important part of treatment is discontinuing of the medication. | |||
Heparin-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | ↑ | For more information click here: Heparin-induced thrombocytopenia. | |||
Immune Thrombocytopenic Purpura (ITP) |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Inherited Thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Thrombotic Thrombocytopenic Purpura (TTP) | History of:
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Hemolytic Uremic Syndrome | History of: | + | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Thromobcytosis | Iron deficiency anemia
Inflammatory diseases |
− | − | − | − | ± | ± | ↑ | Nl or ↑ | Nl | Nl | Nl | − | |||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | Glanzmann’s thrombasthenia |
|
+ | + | + | + | − | Rare | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |
Bernard-Soulier syndrome |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |||
Wiskott-Aldrich syndrome |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl | ||||
Platelet storage pool disorder: |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |||
Acquired Disorders of Platelet Function |
|
+ | + | + | + | ± | ± | Nl or ↓ | ↑ | Nl | Nl | Nl | − | |||
Von Willebrand Disease |
|
+ | + | + | + | ± | ± | ↑ | Nl | ↑ | ↑ | Nl | See the table below for the details about different types. | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Vessel wall disorders | Metabolic and Inflammatory Disorders |
|
|
− | + | + | ± | − | − | Nl | Nl or ↑ | Nl | Nl | Nl | − | |
Inherited Disorders of the Vessel Wall |
|
− | + | + | ± | − | − | Nl | Nl or ↑ | Nl | Nl | Nl | − | |||
Coagulation factor disorders | Fibrinogen deficiency |
Different types of the fibrinogen disorders: |
|
− | − | + | + | ± | + | Nl | ↑ | ↑ | ↑ | ↑ |
| |
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Prothrombin deficiency |
|
− | + | + | + | + | + | Nl | Nl | ↑ | ↑ | ↑ | − | |||
Factor V deficiency |
|
− | _ | + | + | + | + | Nl | ↑ | ↑ | ↑ | Nl | The severity of bleeding is only partly related to the degree of factor V deficiency. Some patients with undetectable plasma levels of factor V experience only relatively mild bleeding. | |||
Factor VII deficiency |
|
+ | + | + | Nl | ↑ | Nl | Nl | Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | |||||||
Factor X deficiency |
|
+ | + | + | + | + | Nl | Nl | ↑ | ↑ | Nl | − | ||||
Factor XII deficiency |
|
_ | _ | _ | _ | _ | Nl | Nl | Nl | ↑ | Nl | |||||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
High molecular weight kininogen (HMWK) deficiency |
|
_ | _ | _ | _ | _ | Nl | Nl | Nl | ↑ | Nl | |||||
Prekallikrein deficiency |
|
_ | _ | _ | _ | _ | Nl | Nl | Nl | ↑ | Nl | |||||
Factor XIII deficiency |
|
|
± | ± | ± | ± | ± | ± | Nl | Nl | Nl or ↑ | Nl | Nl |
| ||
Hemophilia | Type A deficiency |
|
− | − | − | + | + | + | Nl | Nl | Nl | ↑ | Nl | − | ||
Type B deficiency |
|
− | − | − | + | + | + | Nl | Nl | Nl | ↑ | Nl | − | |||
Type C deficiency |
|
− | − | − | + | Rare | Rare | Nl | Nl | Nl | ↑ | Nl | − | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Rare diseases | Disseminated Intravascular Coagulation |
|
+ | + | + | + | + | + | ↓ | ↑ | ↑ | ↑ | Nl | − | ||
Vitamin K Deficiency |
|
+ | − | + | + | + | + | Nl | ↑ | ↑ | Nl or mildly prolonged | Nl | − |
Different types of Von-Willebrand diseases can be differentiated from each other based on the following table:
Type of VWD | Type of factor deficiency | Prevalence | Inheritance pattern | Clinical manifestations | VWF activity | RIPA | Factor VIII | |
---|---|---|---|---|---|---|---|---|
Type 1 | Quantitative/ partial | 60-70% | AD |
|
↓ | ↓ | ↓ | |
Type 2 | 2A | Qualitative | 10% | AD/AR |
|
↓ | ↓ | N or ↓ |
2B | Qualitative | 5% | AD |
|
↓ | ↑ | N or ↓ | |
2M | Qualitative | <1% | AD/AR |
|
↓ | ↓ | N or ↓ | |
2N | Qualitative | <1% | AR |
|
N | N | ↓ | |
Type 3 | Complete deficiency | 1-2% | AR |
|
Absent | ↓ | Low, 1-10% |
For more information on Von Willebrand disease, click here.
- ↑ Invalid
<ref>
tag; no text was provided for refs namedpmid28966616